Videos

Pharmacy students develop concept for exam augmented reality glasses for clinical situations and patient counsling.

Lalan Wilfong, MD, discusses the road to value-based care and payment reform in cancer care.

Lazertinib with amivantamab was found to be similar in efficacy to osimertinib in the MARIPOSA study.

Pharmacists are encouraged to leverage their trusted community role to help manage the anticipated health care burden from respiratory infections this season.

Alessandra Ferrajoli, MD, discusses the importance of renal function for BCL2 inhibitors to avoid tumor lysis syndrome and cardiovascular history for BTK inhibitors to mitigate arrhythmia risks.

Reid Merryman, MD, discusses the potential for minimal residual disease (MRD) to inform treatment decisions, identify lymphoma subgroups, and infer gene expression.

Pharmacy professors discuss their experience implementing a TikTok activity in their curriculum, highlighting the benefits and challenges.

The key opinion leaders explore effective methods for educating patients about pneumococcal vaccination, highlighting its importance and benefits, while also addressing the impact of COVID-19 on vaccine hesitancy and potential fatigue in the general population.

Dr Humphreys discusses pharmacy and provider collaboration.

The panel explores potential barriers to administering newer pneumococcal vaccines, such as payer coverage and patient concerns, while also discussing effective strategies for patient education and emphasizing the necessity and benefits of pneumococcal immunization.

Dr Humphreys discusses key factors to consider when switching to biosimilars.

Stefan Barta, MD, MS, MRCPCUK, discusses the potential role of biomarkers in predicting treatment outcomes, the emerging use of CAR T-cell therapy, and the benefits and challenges of combination therapies in managing T-cell lymphoma.

Sonali Smith, MD, discusses T-cell–directed therapies for indolent B-cell lymphoma, focusing on their efficacy, FDA-approved treatments, and treatment challenges, such as managing cytokine release syndrome.

Educators describe a project where they used TikTok to encourage students to develop innovative informatics and medication safety technologies for fun, engaging learning.

Discount Drug Mart's new pharmacists are excited about the expanding role of community pharmacy in providing personalized, patient-centric health care.

Pharmacy students discuss how they use social media platforms like TikTok, Instagram, and YouTube to reinforce their classroom learning.

Robert Walker discusses the updated COVID-19 vaccines targeting the new JN.1 lineage of the virus and the challenges of addressing vaccine hesitancy to protect individuals and communities.

Dr Humphreys gives advice for states that require prior prescriber approval for substitution.

The key opinion leaders examine the recent approval of PCV21, assessing its potential influence on pneumococcal vaccination strategies, while also identifying and discussing current unmet needs in the field of pneumococcal vaccination.

The vaccination experts analyze the impact of currently approved pneumococcal vaccines on otitis media prevention and compare the newer conjugate vaccines (PCV15 and PCV20) to their predecessors in terms of strain coverage and clinical efficacy.

Dr. Humphreys discusses operationalizing biosimilars in specialty pharmacies.

Jake Galdo and Annie Eisenbeis discuss their vaccine gap closure program and the ability to utilize the model beyond vaccines.

In an initiative to close vaccine gaps in local Missouri communities, pharmacists and community health workers proved essential.

Sophia Humphreys, PharmD, MHA, BCBBS, discusses biosimilar utilization and inventory management.

Sophia Humphreys, PharmD, MHA, BCBBS, discusses the key differences between biologics and biosimilars.

In an interview with Pharmacy Times, Jasmine Perry describes her idea of an effective health care delivery model and why research can have a huge impact at the policy level.

Key opinion leaders examine the pivotal clinical data that supported the FDA approvals of PCV15, PCV20, and PCV21, while also explaining the differences between polysaccharide and conjugate pneumococcal vaccines in terms of their induced immune responses and the durability of protection they offer.

The medical experts explore the importance of receiving PCV20 following PCV13 and PPSV23 vaccinations, while also delving into the broader discussion of how sequential administration of these pneumococcal vaccines may potentially enhance protection against targeted strains.

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

In an interview with Pharmacy Times, Jon Easter discusses the need for pharmacy to align as a profession to achieve policy and research goals.